A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome-Reference-Cited by-同舟云学术

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

Published:2012-03-14 Issue:3 Volume:7 Page:e31334
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Strayer David R.,Carter William A.,Stouch Bruce C.,Stevens Staci R.,Bateman Lucinda,Cimoch Paul J.,Lapp Charles W.,Peterson Daniel L.,Mitchell William M.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Chronic fatigue syndrome: a working case definition.;GP Holmes;Ann Intern Med,1988

2. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.;K Fukuda;Ann Intern Med,1994

3. An examination of the working case definition of chronic fatigue syndrome.;AL Komaroff;Am J Med,1996

4. U.S. Department of Health and Human Services and Centers for Disease Control and Prevention National Center for Infectious Diseases.,2006

5. Chronic fatigue syndrome: An update.;AL Komaroff;Annu Rev Med,1998

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial;Phytomedicine;2024-07

2. Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives;Journal of Clinical Medicine;2024-01-06

3. Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity;International Journal of Biological Macromolecules;2023-12

4. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx;Journal for ImmunoTherapy of Cancer;2023-11

5. Experimental drugs in randomized controlled trials for long-COVID: what’s in the pipeline? A systematic and critical review;Expert Opinion on Investigational Drugs;2023-07-03